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With apologies to Charles Dickens, in the world of biomedical publi-cations, “It is the best of times, it is 
the worst of times”. Scientific productivity, as 
measured by scholarly publication rates, is at 
an all-time high1. However, high-profile cases 
of scientific misconduct remind us that not all 
those publications are to be trusted — but how 
many and which papers? Given the pressure 
to publish, it is important to be aware of the 
ways in which community standards can be 
subverted. Our concern here is with the three 
major sins of modern publishing: duplication, 
co-submission and plagiarism. It is our belief 
that without knowing whether these sins are 
becoming more widespread, the scientific 
community cannot hope to effectively deter 
or catch future unethical behaviour.
There are legitimate and ille-
gitimate reasons for two scientific 
articles to share unusual levels of simi-
larity. Some forms of repeated publication 
are not only ethical, but valuable to the scien-
tific community, such as clinical-trial updates, 
conference proceedings and errata. The most 
unethical practices involve substantial repro-
duction of another study (bringing no novelty 
to the scientific community) without proper 
acknowledgement. If such duplicates have 
different authors, then they may be guilty 
of plagiarism, whereas papers with overlap-
ping authors may represent self-plagiarism. 
Simultaneous submission of duplicate articles 
by the same authors to different journals also 
violates journal policies. 
Previous studies that have 
tried to gauge the level of 
unethical publishing have 
mostly relied on small sur-
veys of specific communities. 
One of the largest to date used 
text-matching software to 
trawl more than 280,000 entries in arXiv, an 
open-access archive of mathematics, physics, 
computer science, biology and statistics papers. 
The study suggested a low number of suspected 
acts of plagiarism (0.2% of arXiv papers), but 
a much higher number of suspected dupli-
cates with the same authors2 (10.5%). In 2002, 
an anonymous survey of 3,247 
US biomedical researchers3 
asking them to admit to 
questionable behaviour 
revealed that 4.7% admit-
ted to repeated 
publication of the 
same results and 1.4% to plagiarism.
In general, the duplication of scientific arti-
cles has largely been ignored by the gatekeep-
ers of scientific information — the publishers 
and database curators. Very few journal edi-
tors attempt to systematically detect duplicates 
at the time of submission. The US National 
Library of Medicine, based in Bethseda, 
Maryland, curates the primary biomedical 
citation index, Medline, and currently reports 
fewer than a thousand cases of duplication 
since the 1950s, discovered 
mainly by serendipity. Yet if 
the results of the anonymous 
survey3 are extrapolated to 
the Medline database (more 
than 17 million citations and 
growing steadily), then you 
would expect to find closer to 
800,000 cases. Where between these two vastly 
different figures does the true number lie? 
The academic arms race
Establishing a baseline is a crucial first step, but 
in our view, monitoring trends is even more 
important to the health of the scientific litera-
ture. As the number of peer-reviewed journals 
has multiplied, the perceived odds of unethical 
publications escaping detection have improved. 
Fortunately, the advent of new computational 
text-searching algorithms, along with electronic 
indexes or full-text electronic manuscripts, is 
also making it easier to detect unethical pub-
lications. Together, these advances enable 
not only the methodical discovery of indi-
vidual incidents, but also a means to 
study broad trends. 
Instead of relying on seren-
dipity to identify duplicate 
articles, we have chosen 
to search online data-
bases, such as Medline, 
using text-simi-
larity software. 
The search engine, 
eTBLAST, is freely available online 
for anyone to use to search the 
literature4. In recent work, we 
have used eTBLAST to search 
a subset of more than 62,000 
Medline abstracts from the past 12 
years to identify highly similar entries5. 
The 421 potential duplicates found have been 
deposited in a publicly available database, 
Déjà vu (http://spore.swmed.edu/dejavu), and 
after manual inspection were confirmed as 
duplicates with different authors (0.04%; based 
on inspection of full-text articles), or duplicates 
with the same authors (1.35%; based on inspec-
tion of the abstracts). The rate of false positives 
in this study was only 1%. But without full text 
it may be difficult to determine if suspected 
duplicates properly attributed the earlier work. 
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Whether or not the duplications are legitimate 
papers has yet to be established.
Extrapolating to the subset of Medline 
records that have abstracts (8.7 million), this 
would correspond to roughly 117,500 dupli-
cates with the same authors4. Although this 
number is far higher than the 739 records cur-
rently annotated as duplicates in Medline, these 
duplication rates are substantially lower than 
those found in arXiv, perhaps reflecting differ-
ences in the database formats (preprints versus 
journal papers), or disparities between these 
fields in what is considered acceptable practice. 
There is also variation in how these estimates 
were reached, including the subjective nature 
of manual inspection (we used two manual 
checkers in each case). The Medline database, 
unlike arXiv, is limited to titles and abstracts, 
and so automated comparison of full-text arti-
cles is not possible, perhaps making it harder to 
detect more sophisticated duplications. 
Closer than close
Because of the sheer size of the Medline data-
base, scaling up the eTBLAST search to all 
17 million records would be extremely time 
consuming even though each search takes only 
about 40 seconds. Fortunately, we observed 
that 73% of the Medline duplicates identified 
in our initial study and curated in Déjà vu also 
feature as the ‘most related article’ in Medline 
(calculated by a Medline algorithm). So, we 
downloaded the related abstracts for 7,064,721 
Medline records, and compared the original 
and related abstracts against one another 
using eTBLAST. This approach allowed us to 
complete our analysis in 10 days rather than 
10 years. In this way we have identified a fur-
ther 70,458 highly simi-
lar records, all of which 
have been deposited 
in Déjà vu.
Given the limita-
tions of our process, we 
expect around 50,000 of 
these to be true dupli-
cates. This is partly because we used a less 
stringent duplication threshold for the latest 
data set and so after manual checking 27% of 
the records turn out to be false positives (see 
http://spore.swmed.edu/dejavu/statistics). To 
date, 2,600 of the Déjà vu records have been 
manually inspected alongside the original, 
but until that is done the status of each entry 
remains unverified. However, extrapolat-
ing to the entire database, we estimate there 
are potentially more than 200,000 duplicates 
in Medline, after various correction factors 
have been applied. 
Although manual verification of the Déjà vu 
database is very much a work in progress, and 
so analysis of the full data set should be inter-
preted with caution, we have started looking 
for trends in the approximately 70,000 candi-
date duplicates.With the articles so far captured 
within the Déjà vu database, merged with anal-
ysis of other data extracted from full-text ver-
sions of Medline articles available in PubMed 
Central (such as publication date, language of 
article and country of origin), it is possible to 
begin to identify broad trends in publication 
behaviour. Perhaps the most obvious is a steady 
rise in the rate of such publications in the bio-
medical literature since 1975 (Figure 1). 
Medline indexes over 5,000 journals pub-
lished in the United States and more than 80 
other countries worldwide. Rising duplicate 
publication rates docu-
mented in Figure 1 are 
therefore a global phe-
nomenon. Potential 
factors contributing to 
this trend are the explo-
sion in the number of 
journals with online 
content (increasing opportunities for unethi-
cal copying), and a body of literature growing 
so fast that the risk of being detected seems 
to diminish. This last factor may be the most 
important, and we believe that automated 
detection processes that can provide an effec-
tive deterrent may be our best weapon in 
fighting duplicate publications. 
One argument for duplicate publication is 
to make significant works available to a wider 
audience, especially in other languages. How-
ever, only 20% of manually verified duplicates 
in Déjà vu are translations into another lan-
guage. What of the examples of text directly 
translated with no reference or credit to the 
original article? Is this justified or acceptable? 
And is such behaviour more widespread for 
review-type articles for which greater dissemi-
nation may be justified? We do not yet have 
answers to these questions.
In general, we find that the duplication rate 
extracted from the total Déjà vu database for 
each country is roughly proportional to the 
number of manuscripts that country con-
tributes to Medline (Figure 2). The top eight 
contributors to Medline are the United States, 
Japan, Germany, China, the United Kingdom, 
Italy, France and Canada, representing close 
to 75% of all Medline records. However, two 
of these countries, China and Japan, have esti-
mated duplication rates that are roughly twice 
that expected for the number of publications 
they contribute to Medline. Perhaps the com-
plexity of translation between different scripts, 
differences in ethics training and cultural 
norms contribute to elevated duplication rates 
in these two countries. 
Simultaneous submission
With few exceptions, the repeated publication 
of the same results by those who conducted 
the research is ethically questionable. It not 
only artificially inflates an author’s publication 
record but places an undue burden on journal 
editors and reviewers, and is expressly forbid-
den by most journal copyright rules. 
Examination of typical submission and pub-
lication dates from 10,000 articles randomly 
selected from PubMed Central, shows that on 
average the review process takes 4.3 months and 
that 97% of articles complete this process within 
10 months (see Supplementary information). 
Curiously, as many as one-third of the manually 
verified duplicate abstracts in Déjà vu sharing 
at least one author are also published less than 
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 Figure 1. Increasing opportunity? The number of biomedical papers indexed in the citation database, 
Medline, has grown steadily over the past 30 years. A search of 7 million abstracts, using the text-
matching software eTBLAST, reveals tens of thousands of highly similar articles (unpublished data), 
which are also growing in number. Are these legitimate or illegitimate publications?
“Automated text-matching 
systems are used by high schools 
and universities. We hold our 
children up to a higher standard 
than we do our scientists.”
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five months after the original. Examination of 
the submission and publication dates of these 
pairs confirms that many of these duplicates 
must have been submitted simultaneously to 
different journals in violation of journal policies 
and accepted norms. For instance, the Déjà vu 
database contains many pairs of highly similar 
abstracts with overlapping authors that appear 
in the same month, all apparently acts of simul-
taneous submission to multiple journals.
Duplication by different authors
Articles sharing excessive similarity with other 
papers with different authors do not necessar-
ily represent plagiarism, as there are sometimes 
valid or trivial reasons (such as a simple author 
name change). However, considering only 
those duplicates in Déjà vu where the full text 
of both articles has been manually inspected, 
we have found 73 plagiarism candidates, most 
of which were previously undetected. Discern-
ing the difference between legitimate and ille-
gitimate duplication is beyond the capacity of 
automated algorithms (and apparently many 
scientists), and so it is critical to withhold 
judgement of any candidate duplicates until 
evaluated by a suitable body such as an edito-
rial board or a university ethics committee. As 
part of our study, we have started to send out 
requests for additional information for such 
cases, one of which has initiated an investiga-
tion by a journal. It is our intent to send such 
requests for information to all individuals and 
journals involved in, or affected by, duplicate 
records with different authors. 
Many duplicate articles without authors in 
common go undiscovered. Are the perpetrators 
then likely to repeat the offence? Searching the 
Déjà vu database reveals several repeat prac-
titioners, and manual inspection of full-text 
articles confirms some of these as suspected 
serial offenders. As with any potential illegiti-
mate duplication, caution and careful human 
judgement must be exercised, and detailed 
comments and manual assessments for these 
and other duplicate pairs can be found within 
the Déjà vu database.
Unlike repeated publication by the same 
authors, simultaneous publication is rarely 
observed for duplicates that do not share 
authors (see Supplementary information), 
undoubtedly due to the fact that it is usu-
ally difficult to re-use someone else’s work 
before it appears in print — unless the dupli-
cating author also happens to have been a 
referee of the original. Although anecdotes 
abound of referees stalling a publication in 
order to give themselves time to duplicate 
and publish the same result first, the gen-
eral lack of duplicates with different authors 
appearing in rapid succession suggests that 
this is either rarer than feared, or that the 
perpetrators do a good job of concealing it.
In general, duplicates are often published in 
journals with lower impact factors (undoubt-
edly at least in part to minimize the odds of 
detection) but this does not prevent negative 
consequences — especially in clinical research. 
Duplication, particularly of the results of 
patient trials, can negatively affect the prac-
tice of medicine, as it can instill a false sense 
of confidence regarding the efficacy and safety 
of new drugs and procedures. There are very 
good reasons why multiple independent stud-
ies are required before a new medical practice 
makes it into the clinic, and duplicate publica-
tion subverts that crucial quality control (not to 
mention defrauding the origi-
nal authors and journals).
What can be done?
Although duplicate publica-
tion and plagiarism are often 
discussed, it seems that dis-
cussion is not enough. Two 
important contributing fac-
tors are the level of confusion over acceptable 
publishing behaviour and the perception that 
there is a high likelihood of escaping detec-
tion. The lack of clear standards for what level 
of text and figure re-use is appropriate (for 
example in the introduction and methods) 
is a well known problem; but the belief that 
one can get away with re-use is probably the 
single most important factor.
Addressing these two aspects could be rela-
tively quick and easy. If journal editors were 
to use more frequently the new computational 
tools to detect incidents of duplicate publi-
cation — and advertise that they will do so 
— much of the problem is likely to take care 
of itself. We find it odd that automated text-
matching systems are used regularly by high 
schools and universities, thereby enabling us to 
hold our children up to a higher standard than 
we do our scientists. In our view, it would be 
fairly simple to fold these tools into electronic-
manuscript submission systems, making it a 
ubiquitous aspect of the publication process. 
Although text-comparison algorithms have 
come a long way in the last 
decade, they are still in their 
infancy, and experience with 
student software shows that 
as tools to detect duplicate 
publication improve, deter-
mined and skilled cheats will 
find ways to defeat them. But 
as in any arms race, the win-
ners are usually determined by the cost–ben-
efit balance, and the costs entailed in unethical 
duplication practices will quickly rise to a 
level that makes them prohibitively expen-
sive to all but the most desperate (or most 
skilled) practitioners.
There are additional practical avenues for 
improving Medline and other databases, such 
as more aggressive enforcement of copyrights 
by journals, and the creation of an ‘update’ 
publication category under which clinical 
updates and longitudinal surveys in sociology 
or psychology could be categorized, and these 
should be explored.
But above all, the fear of having some trans-
gression exposed in a public and embarrass-
ing manner could be a very effective deterrent. 
Like Dickens’s Ebenezer Scrooge, the spectre 
of being haunted by publications past may 
be enough to get unscrupulous scientists to 
change their ways. ■
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Figure 2. Duplication is a global activity. The 
proportion of suspected duplicates in the 
Déjà vu database for each country was estimated 
(unpublished data) by assigning articles to 
countries based on the corresponding author’s 
address. Also presented is each country’s relative 
contribution to Medline estimated from 180,000 
randomly selected Medline articles. 
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